Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

The management of interstitial cystitis: an update

Nature Clinical Practice Urology volume 3, pages 45–53 (2006)Cite this article

Abstract

Treating interstitial cystitis (IC) is one of the greatest challenges facing physicians and other health care providers who manage patients with this condition. The symptoms of urinary frequency and urgency, dysuria, and chronic pelvic pain characterize IC, but it is the debilitating pelvic pain associated with IC that is most difficult to control. The pathophysiology of IC pain is poorly understood, but is thought to be a complex entity including nociceptive, visceral, and neuropathic components. There are currently no universally effective therapies available. Oral treatments, however, are frequently used, including nonsteroidal anti-inflammatory drugs, tricyclic antidepressants, gabapentin, and pentosan polysulfate, all of which have shown varying degrees of efficacy. Recognition that IC pain is multifactorial, and probably has a neuropathic component, has led to the use of some of these agents, previously prescribed for other neurologic conditions associated with chronic pain. Intravesical and surgical options are also available, which expands the armamentarium for those who treat pain secondary to IC. Treating IC requires managing all of the symptoms of this disease. This review aims to cover standard and novel treatment options, while concentrating on the management of pain.

Key Points

  • Interstitial cystitis (IC) is characterized by lower urinary tract symptoms of frequency, dysuria, urgency and chronic pelvic pain

  • The pathophysiology of IC is poorly understood, and several mechanisms have been implicated in this chronic condition

  • The majority of treatments for IC are aimed at treating the pain associated with the disorder, which is the most debilitating symptom

  • Several oral agents have been shown to be effective in controlling the pain associated with IC in some patients, including narcotics, antidepressants, gabapentin and pentosan polysulfate

  • Some invasive therapies such as hydrodistension, intravesIcal treatments and sacral neuromodulation are also being investigated for the treatment of IC

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nordling J (2004) Interstitial cystitis: how should we diagnose it and treat it in 2004? Curr Opin Urol 14: 323–327

    Article  Google Scholar 

  2. Hanno P et al. (2005) International consultation on IC—Rome, September 2004/Forging an international consensus: progress in painful bladder syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor dysfunct 16 (Suppl 1): S2–S34

    Article  Google Scholar 

  3. Jones CA and Nyberg L (1997) Epidemiology of interstitial cystitis. Urology 49: 2–9

    Article  CAS  Google Scholar 

  4. Parsons CL (2003) Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology 62: 976–982

    Article  Google Scholar 

  5. Foster HE (1999) Urologic causes of pelvic pain. Infertility Reprod Med Clin North Am 10: 701–715

    Google Scholar 

  6. Oleary MP et al. (1997) The interstitial cystitis symptom index and problem index. Urology 49 (Suppl 5A): S58–S63

    Article  Google Scholar 

  7. Parsons CL et al. (2002) Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 60: 573–578

    Article  Google Scholar 

  8. Propert KJ et al. (2002) Pitfalls in the design of clinical trials for interstitial cystitis. Urology 60: 742–748

    Article  Google Scholar 

  9. Rovner E et al. (2000) Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 56: 940–945

    Article  CAS  Google Scholar 

  10. Brookoff D (1997) The causes and treatment of pain in interstitial cystitis. In Interstitial Cystitis, 247–255 (Ed Sant GR) Philadelphia: Lippincott–Raven

    Google Scholar 

  11. Ratliff TL et al. (1994) The etiology of interstitial cystitis. Urol Clin N Amer 21: 21–30

    CAS  Google Scholar 

  12. Henry RA et al. (2001) Alkalinized intravesical lidocaine to treat interstitial cystitis: absorption kinetics in normal and interstitial cystitis bladders. Urology 57 (Suppl 1): S119

    Article  Google Scholar 

  13. Parsons CL (2005) Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 65: 45–48

    Article  Google Scholar 

  14. Wong D et al. (1998) Nalmefene: a long acting opioid. J Emerg Med 16: 471–475

    Article  Google Scholar 

  15. Stone N (1994) Nalmefene in the treatment of interstitial cystitis. Urol Clin North Am 21: 101–106

    CAS  PubMed  Google Scholar 

  16. Lynes WL et al. (1987) Mast cell involvement in interstitial cystitis J Urol 138: 746–752

    Article  CAS  Google Scholar 

  17. Theoharides TC et al. (1997) Hydroxyzine therapy for interstitial cystitis. Urology 49 (Suppl 5A): S108–S110

    Article  Google Scholar 

  18. Sant GR et al. (2003) A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 170: 810–815

    Article  CAS  Google Scholar 

  19. Casale TB et al. (1984) Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 73: 775–781

    Article  CAS  Google Scholar 

  20. Sant GR and Theoharides TC (1994) The role of the mast cell in interstitial cystitis. Urol Clin North Am 21: 41–53

    CAS  PubMed  Google Scholar 

  21. Minogiannis P et al. (1998) Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol 20: 553–563

    Article  CAS  Google Scholar 

  22. Kahn B et al. (2005) Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: a consensus report. Curr Med Res Opin 21: 509–516

    Article  Google Scholar 

  23. Mulholland SG et al. (1990) Pentosan polysulfate sodium for the therapy of interstitial cystitis—a double blind placebo controlled clinical study. Urology 35: 552–558

    Article  CAS  Google Scholar 

  24. Nickel JC et al. (2005) Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 65: 654–658

    Article  Google Scholar 

  25. Hanno PM and Wein AJ (1987) Medical treatment of interstitial cystitis (other than Rimso-50/Elmiron). Urology 29 (Suppl): S22–S26

    Google Scholar 

  26. van Ophoven A et al. (2004) A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 172: 533–536

    Article  Google Scholar 

  27. Pilowsky I et al. (1982) A controlled study of amitriptyline in the treatment of chronic pain. Pain 14: 169–179

    Article  CAS  Google Scholar 

  28. Backonga M and Glanzman RL (2003) Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 25: 81–104

    Article  Google Scholar 

  29. Gee NS et al. (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271: 5768–5776

    Article  CAS  Google Scholar 

  30. Nicholson B (2000) Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 101: 359–371

    Article  CAS  Google Scholar 

  31. Sasaki K et al. (2001) Oral gabapentin treatment for refractory genitourinary tract pain. Tech Urol 7: 47–49

    CAS  PubMed  Google Scholar 

  32. Hansen H (2000) Interstitial cystitis and the potential role of gabapentin. South Med J 93: 238–242

    Article  CAS  Google Scholar 

  33. Hindmarch I et al. (2005) A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology 183: 133–143

    Article  CAS  Google Scholar 

  34. Freyhagen R et al. (2005) Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115: 254–263

    Article  Google Scholar 

  35. Soucy F and Gregoire M (2005) Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol 173: 841–843

    Article  CAS  Google Scholar 

  36. Forsell T et al. (1996) Cyclosporine in severe interstitial cystitis. J Urol 155: 1591–1593

    Article  CAS  Google Scholar 

  37. Sairanen J et al. (2004) Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 171: 2138–2141

    Article  CAS  Google Scholar 

  38. Turner K and Stewart H (2005) How do you stretch a bladder? A survey of UK practice, literature review, and a recommendation of a standard approach. Neurourol Urodyn 24: 74–76

    Article  Google Scholar 

  39. Hanno P and Wein A (1991) Conservative therapy for interstitial cystitis. Semin Urol 9: 143–147

    CAS  PubMed  Google Scholar 

  40. Yamada T et al. (2003) Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol 10: 463–468

    Article  Google Scholar 

  41. Moldwin R and Sant GR (2002) Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45: 259–272

    Article  Google Scholar 

  42. Stewart BH et al. (1967) The use of dimethyl sulfoxide (DMSO) in the treatment of interstitial cystitis. J Urol 98: 671–672

    Article  CAS  Google Scholar 

  43. Perez-Marrero R et al. (1988) A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 140: 36–39

    Article  CAS  Google Scholar 

  44. Perez-Marrero R et al. (2003) Prolongation of response to DMSO by heparin maintenance. Urology 41: 64–66

    Article  Google Scholar 

  45. Rossberger J et al. (2005) Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side effects and treatment outcome. Scand J Urol Nephrol 39: 73–77

    Article  Google Scholar 

  46. Zeidman EJ et al. (1994) Bacillus Calmette–Guerin immunotherapy for refractory interstitial cystitis. Urology 43: 121–124

    Article  CAS  Google Scholar 

  47. Peters D et al. (1997) The efficacy of intravesical Tice strain bacillus Calmette–Guèrin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol 157: 2090–2094

    Article  CAS  Google Scholar 

  48. Peters KM et al. (1998) The efficacy of intravesical bacillus Calmette–Guerin in the treatment of interstitial cystitis: long term followup. J Urol 159: 1483–1486

    Article  CAS  Google Scholar 

  49. Mayer R et al. (2005) A randomized controlled trial of intravesical bacillus Calmette–Guèrin for treatment refractory interstitial cystitis. J Urol 173: 1186–1191

    Article  Google Scholar 

  50. Payne CK et al. (2005) Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double blind, placebo controlled trial. J Urol 173: 1590–1594

    Article  CAS  Google Scholar 

  51. Schmidt RA et al. (1979) Urinary bladder and sphincter responses to stimulation of dorsal and ventral sacral roots. Invest Urol 16: 300–304

    CAS  PubMed  Google Scholar 

  52. Hassouna MM et al. (2000) Sacral neuromodulation in the treatment of urgency–frequency symptoms: a multicenter study of efficacy and safety. J Urol 163: 1849–1854

    Article  CAS  Google Scholar 

  53. Abrams P et al. (2003) The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91: 355–359

    Article  CAS  Google Scholar 

  54. Siegel S et al. (2001) Sacral nerve stimulation in patients with intractable pelvic pain. J Urol 166: 1742–1745

    Article  CAS  Google Scholar 

  55. Peters KM and Carey JM (2003) Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 14: 223–228

    Article  CAS  Google Scholar 

  56. Peters KM and Konstandt D (2004) Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 93: 777–779

    Article  CAS  Google Scholar 

  57. Sairanen J et al. (2005) Cyclosporin A and pentosan polysulfate sodium for the treatment of interstitial cystitis. J Urol 174: 2235–2238

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Resident in Urology, Section of Urology, Yale University School of Medicine, New Haven, CT, USA

    Sagar Phatak

  2. Associate Professor of Surgery in the Section of Urology, Yale University School of Medicine, New Haven, CT, USA

    Harris E Foster Jr

Authors
  1. Sagar Phatak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harris E Foster Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harris E Foster Jr.

Ethics declarations

Competing interests

Harris E Foster, Jr is a consultant for Ortho Urology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phatak, S., Foster Jr, H. The management of interstitial cystitis: an update. Nat Rev Urol 3, 45–53 (2006). https://doi.org/10.1038/ncpuro0385

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0385

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing